Insulet (PODD) Liabilities and Shareholders Equity (2010 - 2026)

Insulet has reported Liabilities and Shareholders Equity for 17 years, with the latest figure at $3.0 billion in Q1 2026.

• For the quarter ending Q1 2026, Liabilities and Shareholders Equity fell 15.07% year-over-year to $3.0 billion; the trailing twelve-month figure through Mar 2026 stood at $12.7 billion (up 1.31% YoY), and the FY2025 full-year result was $3.2 billion, up 3.33% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $3.0 billion, down from $3.2 billion in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $3.5 billion in Q1 2025, with the low at $2.1 billion in Q1 2022.
• Historically, Liabilities and Shareholders Equity has averaged $2.7 billion across 5 years, with a median of $2.6 billion in 2024.
• Annual changes were most pronounced in 2025 — Liabilities and Shareholders Equity soared 34.04% — and 2026, when it declined 15.07%.
• Insulet's Liabilities and Shareholders Equity stood at $2.3 billion in 2022, then climbed by 14.97% to $2.6 billion in 2023, then grew by 19.3% to $3.1 billion in 2024, then advanced by 3.33% to $3.2 billion in 2025, then fell by 6.37% to $3.0 billion in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $3.0 billion (Q1 2026), $3.2 billion (Q4 2025), and $3.0 billion (Q3 2025), per Business Quant data.